Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × neratinib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thrombocytosis 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1

Interventions

Gemcitabine 82 Cisplatin 65 Capecitabine 34 Oxaliplatin 31 durvalumab 29 pembrolizumab 24 Fluorouracil 23 Leucovorin 22 S 1 (combination) 16 lenvatinib 12 Nivolumab 12 Irinotecan 12 tremelimumab 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 9 Injections 7 Immune Checkpoint Inhibitors 7 Docetaxel 7 apatinib 6 Trastuzumab 6 titanium silicide 5 surufatinib 5 irinotecan sucrosofate 5 camrelizumab 5 Folfox protocol 5 Drug Therapy 5 Carboplatin 5 Blood Specimen Collection 5 Albumin-Bound Paclitaxel 5 zanidatamab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05615818 2025-04-23

SAFIR-ABC10

UNICANCER

Phase 3 Recruiting

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡